The sales agreement will comprise transfer of development, production and sales of mushrooms, licensing, and sales of active agents. The sales are based on Takara’s management plan 2019 which promotes the three business divisions of “Biotechnology support business”, “Genetic medicine business” and “Medical food bio business”.

Takara Bio news release, December 17, 2018